Definitive Healthcare (DH) to Release Quarterly Earnings on Thursday

Definitive Healthcare (NASDAQ:DH) is anticipated to announce its Q2 2025 earnings results after the market closes on Thursday, August 7th. Analysts expect the company to announce earnings of $0.05 per share and revenue of $59.22 million for the quarter. Definitive Healthcare has set its FY 2025 guidance at 0.200-0.230 EPS and its Q2 2025 guidance at 0.040-0.050 EPS.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. Definitive Healthcare had a negative net margin of 206.05% and a positive return on equity of 3.69%. The company had revenue of $59.19 million during the quarter, compared to analysts’ expectations of $56.20 million. During the same quarter in the prior year, the company earned $0.08 EPS. Definitive Healthcare’s revenue was down 6.8% compared to the same quarter last year. On average, analysts expect Definitive Healthcare to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Definitive Healthcare Stock Down 2.0%

Shares of NASDAQ DH opened at $4.00 on Thursday. Definitive Healthcare has a 12-month low of $2.15 and a 12-month high of $5.68. The stock has a market cap of $594.56 million, a PE ratio of -0.91, a P/E/G ratio of 6.87 and a beta of 1.64. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.37. The company has a 50-day moving average of $3.80 and a 200 day moving average of $3.63.

Hedge Funds Weigh In On Definitive Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the company. Jane Street Group LLC lifted its holdings in shares of Definitive Healthcare by 166.0% in the 1st quarter. Jane Street Group LLC now owns 105,114 shares of the company’s stock worth $304,000 after acquiring an additional 65,597 shares during the last quarter. AQR Capital Management LLC lifted its holdings in shares of Definitive Healthcare by 56.7% in the 1st quarter. AQR Capital Management LLC now owns 590,149 shares of the company’s stock worth $1,706,000 after acquiring an additional 213,562 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Definitive Healthcare by 564.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock worth $25,191,000 after acquiring an additional 7,404,363 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently issued reports on DH shares. The Goldman Sachs Group upped their price objective on shares of Definitive Healthcare from $3.00 to $3.40 and gave the company a “neutral” rating in a research note on Monday, May 12th. BTIG Research lowered shares of Definitive Healthcare from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. Finally, Wall Street Zen upgraded shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, June 21st. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $5.10.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.